Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.

Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.

Artificial intelligence is rapidly inventing new drugs for diseases from Parkinson's disease and antibiotic-resistant superbugs to rare lung conditions.

Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.

"Medicare was built on evidence-based medicine," said Duane Boise, CEO of MMJ International Holdings. "If cannabinoid therapies are going to be reimbursed by federal healthcare programs, they should m ...

Many companies are just now deciding they want to be pharmaceutical, but the real barrier to entry is time spent inside the regulatory process. MMJ International Holdings made that commitment nearly a ...

Industry groups have identified upfront costs as a barrier to streamlining U.S. drugmaking. The nonprofit API Innovation Center has a proposed answer for how to tilt finances in favor of investments ...

To date, 41 brands spanning the makeup, skin care, hair care and fragrance categories have graduated from the program.

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

"The stories are so outrageous," Senator Ron Johnson said. "It just appears that they’re looking for excuses to say no." ...

Duane Boise CEO MMJ International Holdings stated "You cannot shortcut the FDA. Many companies are just now deciding they want to be pharmaceutical, but the real barrier to entry is time spent inside ...

Federal health officials on Monday laid out a proposal to spur development of customized treatments for patients with hard-to ...